Cencora, Inc.
As of Oct 22, 2026, Cencora is in Stage 2, the uptrend phase, now in week 4 (since Oct 1, 2026). It closed at $338.48, 9.1% below its 52-week high and above its 200-day average, which is falling.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 3 in Medical Distribution · #1 of 272 in Health Care
Is COR early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
COR among Medical Distribution5th of 11 by relative strength
All 11 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | FOCL | Stage 4 · wk 1 | 92 | −12.4% |
| 2 | CAH | Stage 2 · wk 1 | 90 | +15.8% |
| 3 | HSIC | Stage 3 · wk 1 | 79 | +1.1% |
| 4 | MCK | Stage 2 · wk 7 | 76 | +15.0% |
| 5 | COR | Stage 2 · wk 4 | 58 | +8.4% |
| 6 | AHG | Stage 4 · wk 16 | 36 | +58.4% |
| 7 | YI | Stage 4 · wk 16 | 32 | −17.3% |
| 8 | COSM | Stage 1 · wk 7 | 13 | −37.8% |
Cencora: quick answers
What stage is Cencora in?
As of Oct 22, 2026, Cencora (COR) is in Stage 2, the uptrend phase. It entered Stage 2 on Oct 1, 2026 and is in week 4. What the four stages mean
Is Cencora in an uptrend?
Yes. Cencora is in a Stage 2 uptrend. It trades 6.9% above its 200-day average, which is falling.
How far is Cencora from its 52-week high?
Cencora closed at $338.48 on Oct 22, 2026, 9.1% below its 52-week high of $372.53. Its 52-week low is $251.67.
How has Cencora performed over the past year?
As of Oct 22, 2026, Cencora is up 3.7% over the past year and up 0.5% so far in 2026.
Which sector and industry is Cencora in?
Cencora is in the Medical Distribution industry, part of the Health Care sector.
About this companyHealth Care· Medical Distribution
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.